Canada Autoimmune Disease Diagnostics Market Size & Outlook, 2025-2029
Canada Autoimmune Disease Diagnostics Market Size
According to Straits Research analysis, the Canada Autoimmune Disease Diagnostics Market was valued at USD 215.83 Million in 2024 and is projected to reach USD 309.05 Million by 2029, expanding at a CAGR of 7.6% during the forecast period. The primary stimulator of this growth is the mounting prevalence of autoimmune diseases such as rheumatoid arthritis and systemic lupus erythematosus. The medical sector's continuous emphasis on advanced diagnostic techniques bolsters the demand for efficient disease management. Technological advancements, like the enhancement of biochips and portable devices for autoimmune disease diagnostics, represent emerging opportunities. Furthermore, the increasing awareness about autoimmune diseases further fuels the market. Going forward, Canada's commitment to research and development in medical technology is expected to position the country as a significant player in the global autoimmune disease diagnostics market.
Source: Straits Research Analysis Company Publications, Primary Interviews.
Canada Autoimmune Disease Diagnostics Market Highlights
- By segment, Consumables & Assay Kits emerged as the largest Product in terms of market size in 2024.
- Consumables & Assay Kits is anticipated to remain the most attractive Product segment, recording the fastest growth during the forecast period.
- In 2024, Canada accounted for 3.92% of the global autoimmune disease diagnostics market size.
- By 2029, United States is expected to lead the global autoimmune disease diagnostics market in terms of market size.
- Within North America, United States is projected to dominate the regional autoimmune disease diagnostics market size by 2029.
- Canada is identified as the fastest-growing market in North America, anticipated to reach USD 24106 Million by 2029.
- 📊 Preview Report Scope and Structure – Gain immediate visibility into key topics, market segments, and data frameworks covered.
- 📥 Evaluate Strategic Insights – Access selected charts, statistics, and analyst-driven commentary derived from the final report deliverables.
Report Summary
| Report Scope | Details |
|---|---|
| Base Year for Study | 2024 |
| Study Period | 2021-2029 |
| Historical Period | 2021-2023 |
| Forecast Period | 2025-2029 |
| Market Size In 2024 | USD 215.83 Million |
| Market Size In 2029 | USD 309.05 Million |
| Largest segment | Consumables & Assay Kits |
| Fastest segment | Consumables & Assay Kits |
| Units | Revenue in USD Million |
| CAGR | 7.6% (2025-2029) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends |
Canada Autoimmune Disease Diagnostics Market Share By Product
Segmentation Covered
| Segments | Sub Segments |
|---|---|
| Product |
|
| Test type |
|
| Target disease |
|
| Systemic Autoimmune Disease, by Type |
|
| Localized Autoimmune Disease, by Type |
|
| End User |
|
Canada Autoimmune Disease Diagnostics Market By Product 2029
Source: Straits Research Analysis Company Publications, Primary Interviews.
Canada Autoimmune Disease Diagnostics Market By Test type 2029
Source: Straits Research Analysis Company Publications, Primary Interviews.
Canada Autoimmune Disease Diagnostics Market By Target disease 2029
Source: Straits Research Analysis Company Publications, Primary Interviews.
Canada Autoimmune Disease Diagnostics Market By Systemic Autoimmune Disease, by Type 2029
Source: Straits Research Analysis Company Publications, Primary Interviews.
Canada Autoimmune Disease Diagnostics Market By Localized Autoimmune Disease, by Type 2029
Source: Straits Research Analysis Company Publications, Primary Interviews.
Canada Autoimmune Disease Diagnostics Market By End User 2029
Source: Straits Research Analysis Company Publications, Primary Interviews.
